Rhenman & Partners Asset Management AB »

Stoke Therapeutics shares owned by Rhenman & Partners Asset Management AB

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Rhenman & Partners Asset Management AB from 13F filings

Historical chart of Rhenman & Partners Asset Management AB investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Rhenman & Partners Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 83k 32.56
2025-12-31 $6.9M 216k 31.74
2025-09-30 $5.9M 250k 23.50